Clinical Trial Update: Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating veliparib plus pembrolizumab and chemotherapy in locally advanced rectal cancer has completed and posted results in 2023. The study inv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2023-06-09